Advances in the Treatment of HR+ HER2 negative early Breast Cancer
Prof. Ella Evron, Head, Breast Cancer Service, Kaplan Medical Center
Pathological and Multi-Gene Molecular Assessment of Early Breast Tumors for Systemic Treatment Considerations
Dr. Nava Siegelmann-Danieli, Director, Oncology Service Line, Maccabi Health Services
The Israeli Experience with Genetic Testing in Breast Cancer Patients
Dr. Rinat Bernstein-Molho, Director, The Suzanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer
Optimal Management in the Treatment of ER-Positive, HER2-Negative Metastatic Breast Cancer
Dr. Amir Sonnenblick, Head, Breast Cancer Unit, Tel-Aviv Sourasky Medical Center
Reproduction in Breast Cancer Patients
Prof. Dror Meirow, Director, Morris Kahn Fertility Preservation Center, Sheba Medical Center, Tel Hashomer. Former President of the International Society for Fertility Preservation (ISFP)
Considerations in Radiation Oncology Following Neo- Adjuvant Therapy
Dr. Merav Ben David, Medical and Radiation Oncologist, Head, Radiation Oncology Department, Assuta Medical Center
לחלק הראשון, לחץ/י כאן
Sponsored by Roche.